3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Odontogenic Cysts
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Neuroendocrine Tumors
1
Lung Neoplasms
1
Liver Neoplasms
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Neuroendocrine
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
Oxaliplatin
16
Cetuximab
13
Leucovorin
12
Fluorouracil
12
Bevacizumab
10
pembrolizumab
7
Specimen Handling
7
Nivolumab
7
Magnetic Resonance Spectroscopy
6
Irinotecan
6
Capecitabine
6
encorafenib
4
Pemetrexed
4
Gemcitabine
4
Cisplatin
4
cemiplimab
3
Folfox protocol
3
Early Intervention, Educational
3
Celecoxib
3
Carboplatin
3
Biopsy
3
trifluridine tipiracil drug combination
2
relatlimab
2
pertuzumab
2
palbociclib
2
fludarabine
2
durvalumab
2
dehydroftorafur
2
aldesleukin
2
adagrasib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Radionuclide Imaging
×
90 days
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled